ambroxol has been researched along with Nasal Catarrh in 1 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nimesulide treatment for 7 to 10 days is shown to be effective in controlling the inflammatory process in upper airways disorders such as rhinitis, rhinosinusitis, rhinopharyngitis and tubaritis, and in middle ear disorder (secretory otitis media)." | 5.07 | Treatment of upper airways inflammation with nimesulide. ( Bellussi, L; Passàli, D, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellussi, L | 1 |
| Passàli, D | 1 |
1 trial available for ambroxol and Nasal Catarrh
| Article | Year |
|---|---|
Treatment of upper airways inflammation with nimesulide.
Topics: Adolescent; Adult; Aged; Ambroxol; Anti-Inflammatory Agents, Non-Steroidal; Child; Drug Therapy, Com | 1993 |